Preferred Label : Dabigatran Etexilate;

NCIt synonyms : Ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate;

UNII : 2E18WX195X;

InChIKey : KSGXQBZTULBEEQ-UHFFFAOYSA-N;

CAS number : 211915-06-9;

Drug name : Pradax;

Molecule name : BIBR 1048 BS RS1;

Chemical formula : C34H41N7O5;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3478094/fr/pradaxa-dabigatran-etexilate-traitement-des-evenements-thromboemboliques-veineux-etev-pediatrique
2024
false
false
false
France
child
adolescent
evaluation of the transparency committee
pediatrics
During Treatment
Biomaterial Treatment
Treatment
Venous Thromboembolism
Dabigatran Etexilate Mesylate
Treatment Study
pediatrician
On Treatment
venous thromboembolism
GDC Treatment Frequency Terminology
Treatment Epoch
Pediatric
vein, nos
Childhood-Onset Systemic Lupus Erythematosus
Thromboembolic Event, CTCAE
Pradaxa
Pediatric
Pediatricians
Therapy Object
Dabigatran Etexilate
dabigatran etexilate
thromboembolus
No Treatment for Diabetes
Dabigatran
thromboembolism
Treat

---
Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.